LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC)

CUSIP: 519345102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / CLASS A COM
Total 13F shares
10,132,616
Share change
+523,492
Total reported value
$103,772,882
Price per share
$10.25
Number of holders
53
Value change
+$5,473,851
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 519345102?
CUSIP 519345102 identifies LVAC - LAVA MEDTECH ACQUISITION COR - CLASS A COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC) as of Q4 2022

As of 31 Dec 2022, LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,132,616 shares. The largest 10 holders included Saba Capital Management, L.P., Periscope Capital Inc., Polar Asset Management Partners Inc., Shaolin Capital Management LLC, Castle Creek Arbitrage, LLC, Governors Lane LP, Sculptor Capital LP, MARSHALL WACE, LLP, Balyasny Asset Management LLC, and Westchester Capital Management, LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.